Advances on the study of the pharmacological effects of artemisinin and its derivatives

Abstract

Abstract: Artemisinin is a sesquiterpene lactone compounds, their derivatives include mainly dihydroartemisinin, artesunate, artemether and Artemisia ether. These drugs are now mainly used for clinical treatment of malaria. With the pharmacological action of artemisinin and its derivatives have been further studied, except antimalarial effects, researchers have found their anti-inflammatory, anti-sepsis, antitumor, radiosensitization, antimicrobial sensitivity, anti-fibrosis effects in recent years. Here, we collect and review the most newly pharmacological effects of artemisinin and its derivatives all over the world in past years.

Key words: Artemisinin, Derivates, Pharmacological action

CLC Number:

LI Bin, ZHOU Hong. Advances on the study of the pharmacological effects of artemisinin and its derivatives[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(5): 572-576.

References

[1] Praygod G, de Frey A, Eisenhut M. Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review[J]. MalarJ, 2008,7:210.
[2] Tahar R, Ringwald P, Basco LK. Molecular epidemiology of malaria in Cameroon. XXVIII. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum and sequence analysis of the P. falciparum ATPase 6 gene[J]. Am J Trop Med Hyg, 2009, 81(1): 13-18.
[3] Wong HR, Menendez IY. Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells[J]. Biochem Biophys Res Commun, 1999, 262(2): 375-380.
[4] He Y, Fan J, Lin H, et al. The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in human rheumatoid arthritis fibroblast-like synoviocyte[J]. Rheumatol Int, 2009. [Epub ahead of print]
[5] Li WD, Dong YJ, Tu YY, et al. Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation[J]. Int Immunopharmacol, 2006, 6(8): 1243-1250.
[6] Graziose R, Lila MA, Raskin I. Merging traditional chinese medicine with modern drug discovery technologies to find novel drugs and functional foods[J]. Curr Drug Discov Technol, 2010, 6. [Epub ahead of print]
[7] 王俊, 周红. 青蒿素对CpG DNA 攻击小鼠保护作用的实验研究[J]. 中国临床药理学与治疗学, 2005, 10(3): 290-293.
[8] 李斌, 张蓉, 王俊, 等. 双氢青蒿素对CpG ODN诱导小鼠RAW264.7细胞释放细胞因子的影响[J]. 四川生理科学杂志, 2005, 27(4): 149-152.
[9] Li B, Li J, Pan X, et al. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation[J]. Int Immunopharmacol, 2010, 10(3): 344-350.
[10] 谭余庆, 赵一, 林启云, 等. 青蒿提取物抗内毒素实验研究[J]. 中国中药杂志, 1999, 3: 38-43.
[11] 梁爱华, 薛宝云, 王金华, 等. 青蒿琥酯对内毒素诱导的炎性因子合成抑制作用的研究[J]. 中国中西医结合急救杂志, 2001, 8(5): 262-265.
[12] 张培, 陈雪梅, 罗炳德, 等. 青蒿琥酯对内毒素信号转导通路中CD14的影响[J]. 中国公共卫生, 2006, 22(3): 284-285.
[13] 郭进强,李莉,万为人,等. 青蒿琥酯抗中暑内毒素血症的机制探讨[J]. 南方医科大学学报, 2008, 28(7): 1290-1291.
[14] Wang J, Zhou H, Zheng J, et al. The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release[J]. Antimicrob Agents Chemother, 2006, 50(7): 2420-2427.
[15] 曹红卫, 郭毅斌, 王宁, 等. 青蒿素对脓毒症大鼠的保护作用[J]. 第三军医大学学报, 2005, 27(17): 1769-1772.
[16] Li B, Zhang R, Li J, et al. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation[J]. Int Immunopharmacol, 2008, 8(3): 379-389.
[17] 王宁, 刘鑫, 周红, 等. 青蒿琥酯对盲肠结扎穿孔术脓毒症小鼠的保护作用[J]. 中国临床药理学与治疗学, 2008, 13(10): 1095-1098.
[18] Lu YY, Chen TS, Qu JL, et al. Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells[J]. J Biomed Sci, 2009, 16(1): 16.
[19] Zhou HJ, Zhang JL, Li A, et al. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro[J]. Cancer Chemother Pharmacol, 2009. [Epub ahead of print]
[20] Lai H, Nakase I, Lacoste E, et al. Artemisinin-transferrin conjugate retards growth of breast tumors in the rat[J]. Anticancer Res, 2009, 29(10): 3807-3810.
[21] Wu ZP, Gao CW, Wu YG, et al. Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model[J]. Integr Cancer Ther, 2009, 8(1): 88-92.
[22] 张祖贻, 余世庆, 苗立云, 等. 青蒿琥酯联合NP 方案治疗中晚期非小细胞肺癌的随机对照研究[J]. 中西医结合学报, 2008, 6(2): 134-138.
[23] Chen H, Sun B, Pan S, et al. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo[J]. Anticancer Drugs, 2009,20:131-140.
[24] 张居馨, 王士贤, 张富庚, 等. 青蒿琥酯对人宫颈癌HeLa细胞的乏氧杀伤和辐射增敏作用初探[J]. 癌症, 2001, 20(12): 1363-1366.
[25] Kim SJ, Kim MS, Lee JW, et al. Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro[J]. J Cancer Res Clin Oncol, 2006, 132(2): 129-135.
[26] 宫晓梅,曹建平,樊赛军, 等. 青蒿素对人宫颈癌细胞放射增敏作用及其机制的研究[J]. 肿瘤, 2009, 20(10): 950-954.
[27] 董俊清, 赵妍妍, 姚琦, 等. 青蒿琥酯增加人脑胶质瘤细胞CHG-5对β射线的敏感性[J]. 第三军医大学学报, 2010, 32(6): 588-592.
[28] 曾静,曹建平,樊赛军. 辐射研究与辐射工艺学报[J]. 肿瘤, 2008, 26(5): 257-260.
[29] 郑红艳. 青蒿素母液体外抗真菌试验[J]. 四川畜牧兽医, 2001, 28(5): 33-34.
[30] 金慧玲, 张汝芝, 高玉祥,等. 青蒿琥酯抗真菌、抗细菌的实验研究[J]. 中国微生态学杂志, 2003,15(1): 26-28.
[31] 马捷, 陈丽华, 廖荣, 等. 蒿甲醚、双氢青蒿素对小鼠硬皮病模型的影响[J]. 中国中药杂志, 2009, 34(2): 204-207.
[32] 农晓琳,陈洪,陈石海,等. 青蒿素、青蒿琥酯抗皮肤瘢痕的体外实验研究[J]. 广西医科大学学报, 2009, 26(2): 202-205.
[33] 江川,贺光照,冯登超. 青蒿琥酯对体外瘢痕疙瘩成纤维细胞的抑制作用[J]. 重庆医科大学学报, 2009, 30(10): 1351-1354.
[34] 许光兰, 陈平, 梁劲松, 等. 青蒿琥酯对实验性肺纤维化大鼠治疗作用及其机理研究[J]. 临床医学工程, 2009, 16(9): 6-8.
[35] 李文桂, 陈雅棠, 刘成伟. 双氢青蒿素治疗大鼠卡氏肺孢子虫肺炎后的肺脏病理变化观察[J]. 动物医学进展, 2004, 25(1): 94-97.
[36] 汤自豪, 周小鸥, 高兴政, 等. 双氢青蒿素、甲硝唑及两药联合应用体外抗阴道毛滴虫效果的研究[J]. 中国医科大学学报, 2008, 37(2): 200-204.